Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohortAndrea Serafin, Andrea Visentin, Monia Marchetti et al.|Blood Advances|2025Cited by 3
<i>CAT</i> rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic LeukemiaMarilisa Galasso, Maria Teresa Scupoli, Vittoria Salaorni et al.|Hematological Oncology|2024Cited by 1
Author response for "<i>CAT</i> rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia"Marilisa Galasso, Maria Teresa Scupoli, Vittoria Salaorni et al.|Unknown|2024Cited by 0